THORN RUN PARTNERS

Lobbying for ARDELYX, INC. · Pharmaceutical manufacturer

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to Medicare ESRD benefit and chronic kidney disease management.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem